March 24, 2025

Tildrakizumab Shows Lasting Efficacy in Scalp Psoriasis

Tildrakizumab may provide durable response for scalp psoriasis, a phase 3b study found, confirming sustained efficacy and safety through 52 weeks.

Conexiant

March 24, 2025

TPT Lowers Tuberculosis Risk in Rheumatic Patients

TPT decreased the overall risk of tuberculosis disease in patients with rheumatic diseases, with a 76% risk reduction observed in certain subgroups, researchers reported.

Conexiant

March 21, 2025

Biosimilars Match Adalimumab Originator Efficacy for Psoriasis

Amjevita and Imraldi were as effective as Humira for both new starters and patients switching from Humira, researchers concluded

Conexiant

March 21, 2025

Peripheral Biomarker Signatures May Improve RA-ILD Detection

Distinct peripheral biomarker signatures improved RA-ILD identification beyond clinical risk factors, with an AUC of 0.751.

Conexiant

March 19, 2025

Study: Sex Differences in Physician Suicide

Researchers found that female physicians had a significantly higher suicide risk than female nonphysicians.

Conexiant

March 14, 2025

High BMI Driving Osteoarthritis Surge Among Postmenopausal Women: Study

Researchers report in a new global study, highlighting a 139.8% increase in prevalence since 1990.

Conexiant

March 14, 2025

Colchicine Tied to Fewer CV Events in Gout

Patients with gout initiating urate-lowering therapy had a reduced risk of cardiovascular events when prescribed colchicine prophylaxis, researchers report.

Conexiant

March 14, 2025

CADM Misdiagnosed Twice as Often as DM, Linked to Poorer Outcomes

Study reveals CADM patients face twice the misdiagnosis rate of DM patients, with diagnostic delays associated with increased hospitalization and ILD risks.

Conexiant

March 12, 2025

Muscle Protein Synthesis Not Influenced by Menstrual Cycle Phase: Study

Skeletal muscle is not more anabolically responsive to resistance exercise in a particular menstrual cycle phase, researchers report.

Conexiant